Friday, July 10, 2026

Drug profile · INN

plazomicin (sulfate)

plazomicin (sulfate) (ZEMDRI) is a bacterial 70s ribosome inhibitor.

EMA: application withdrawn
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — plazomicin (sulfate)
Class
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

plazomicin (sulfate) (ZEMDRI) is a bacterial 70s ribosome inhibitor.

Key facts

INN plazomicin (sulfate)
Brand ZEMDRI
Mechanism Bacterial 70S ribosome inhibitor
Target Bacterial 70S ribosome

Mechanism of action

Bacterial 70S ribosome inhibitor

Primary target: Bacterial 70S ribosome

Approval history

Authority Status Date
EMA application withdrawn

Related & competitor drugs

  1. azithromycin Bacterial 70S ribosome inhibitor
  2. chloramphenicol Bacterial 70S ribosome inhibitor
  3. clarithromycin Bacterial 70S ribosome inhibitor
  4. clindamycin hydrochloride Bacterial 70S ribosome inhibitor
  5. clindamycin palmitate hydrochloride Bacterial 70S ribosome inhibitor
  6. clindamycin phosphate Bacterial 70S ribosome inhibitor

Frequently asked questions

What is plazomicin (sulfate)?

plazomicin (sulfate) (ZEMDRI) is a bacterial 70s ribosome inhibitor.

What is the brand name for plazomicin (sulfate)?

ZEMDRI is a marketed brand name for plazomicin (sulfate). Check FDA Drugs@FDA for the current US label holder and prescribing information.